Last reviewed · How we verify

NCT04382560

Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic

Completed NA Last updated 1 April 2021
What this trial tests

NA trial testing Deep Breathing training in Behavior, Social in 69 participants. Completed in 31 May 2020.

Timeline
2 May 2020
Primary endpoint
31 May 2020
31 May 2020

Quick facts

Lead sponsorUniversity of Parma
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment69
Start date2 May 2020
Primary completion31 May 2020
Estimated completion31 May 2020
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Parma

Who can join

Adults 20 to 50, any sex, with Behavior, Social or Autonomic Imbalance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study investigates the efficacy of a brief and cost-effective video-intervention that combines bottom-up elements of deep breathing and third-wave cognitive behavioral therapy techniques (i.e., mindfulness and compassion) on coping strategies during the COVID-19 pandemic.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Safe in my heart: resting heart rate variability longitudinally predicts emotion regulation, worry and sense of safeness during COVID-19 lockdown
    Makovac E, Carnevali L, Hernandez-Medina S, Sgoifo A, et al · · 2021 · DOI 10.1101/2021.06.17.21259071

Verify or expand the search:

Other recruiting trials for Behavior, Social

Currently open trials in the same condition.

Other University of Parma trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04382560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing